| 1 |
Li M, Zhang W, Li J, Qi Y, Peng C, Wang N, Fan H, Li Y. Zwitterionic polymers: addressing the barriers for drug delivery. Chinese Chemical Letters 2023. [DOI: 10.1016/j.cclet.2023.108177] [Reference Citation Analysis]
|
| 2 |
Hameedat F, Pinto S, Marques J, Dias S, Sarmento B. Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides. Drug Deliv Transl Res 2023. [PMID: 36587110 DOI: 10.1007/s13346-022-01286-4] [Reference Citation Analysis]
|
| 3 |
Liu W, Ma R, Lu S, Wen Y, Li H, Wang J, Sun B. Acid-Resistant Mesoporous Metal-Organic Frameworks as Carriers for Targeted Hypoglycemic Peptide Delivery: Peptide Encapsulation, Release, and Bioactivity. ACS Appl Mater Interfaces 2022;14:55447-57. [PMID: 36478454 DOI: 10.1021/acsami.2c18452] [Reference Citation Analysis]
|
| 4 |
Zhang Y, Wang Y, Li X, Nie D, Liu C, Gan Y. Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications. J Control Release 2022;352:813-32. [PMID: 36368493 DOI: 10.1016/j.jconrel.2022.11.010] [Reference Citation Analysis]
|
| 5 |
Li X, Fang S, Yu Y, Yang H, Rao Y, Hong D, Lu C, Yu M, Lu X, Yu C, Zhao Q. Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease. Chemical Engineering Journal 2022;445:136438. [DOI: 10.1016/j.cej.2022.136438] [Reference Citation Analysis]
|
| 6 |
Hameedat F, Pizarroso NA, Teixeira N, Pinto S, Sarmento B. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment. Eur J Pharm Sci 2022;176:106259. [PMID: 35842140 DOI: 10.1016/j.ejps.2022.106259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
De Marchi JGB, Cé R, Onzi G, Alves ACS, Santarém N, Cordeiro da Silva A, Pohlmann AR, Guterres SS, Ribeiro AJ. IgG functionalized polymeric nanoparticles for oral insulin administration. Int J Pharm 2022;:121829. [PMID: 35580686 DOI: 10.1016/j.ijpharm.2022.121829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Vitulo M, Gnodi E, Meneveri R, Barisani D. Interactions between Nanoparticles and Intestine. IJMS 2022;23:4339. [DOI: 10.3390/ijms23084339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Li Y, Zhang W, Zhao R, Zhang X. Advances in oral peptide drug nanoparticles for diabetes mellitus treatment. Bioact Mater 2022;15:392-408. [PMID: 35386357 DOI: 10.1016/j.bioactmat.2022.02.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
